KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

15 mg fampridine-SR (4-aminopyridine, 4-AP)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

20 mg fampridine-SR (4-aminopyridine, 4-AP)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

4-Aminopyridine

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[2] 3, 13 💬

Dalfampridine
(4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[2] 4, 13 💬

Dalfampridine ER
(4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
(4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Dalfampridine-ER 10mg
(4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Dalfampridine-ER 5mg
(4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Sustained-release oral dalfampridine
(4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬